臻里生技和高雄榮總共同發表國際論文

今年2月在國際醫學期刊Ethnopharmacology的一篇以台灣骨碎補的指標成分為題的研究被發表出來。文章內容是關於台灣骨碎補的指標成分(ECAP)可以抑制因關節炎或風濕性關節炎所引起的細胞間質蛋白質分解酵素(MMP2)。同時也可以因MMP2的抑制而減少發炎部位的血管新生。

Journal of Ethnopharmacology 196 (2017) 213–224

Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/ TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells

Chun-Ting Liua, , Kuo-Wei Bia, , Chao-Chun Huang , Hsiao-Ting Wu , Hui-Ya Ho , JongHwei S. Pangd,e,⁎ , Sheng-Teng Huangf,g,⁎⁎

a Department of Chinese Medicine and Mitochondrial Research Unit, Chang Gung Memorial Hospital–Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan

b Division of General Surgery, Ministry of Health and Welfare Pingtung Hospital, Pingtung, Taiwan

c Jen Li Biotech Company Ltd., Taiping District, Taichung 41143, Taiwan d Graduate Institute of Clinical Medical Sciences, Chang Gung University, Tao-Yuan,Taiwan

e Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital, Taoyuan, Taiwan

f Department of Chinese Medicine, China Medical University Hospital, Taichung, Taiwan

g School of Chinese Medicine, China Medical University, Taichung, Taiwan

Back_to_top